LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 125, Issue 1, Pages 304-315
Publisher
American Society for Clinical Investigation
Online
2014-12-08
DOI
10.1172/jci76357
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
- (2013) Michelle Fanale et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advances in targeting cell surface signalling molecules for immune modulation
- (2013) Sheng Yao et al. NATURE REVIEWS DRUG DISCOVERY
- Epstein–Barr virus maintains lymphomas via its miRNAs
- (2013) D T Vereide et al. ONCOGENE
- Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
- (2013) Obinna Chijioke et al. Cell Reports
- The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8
- (2013) Shuvomoy Banerjee et al. PLoS Pathogens
- Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
- (2013) Lenka Skalska et al. PLoS Pathogens
- A Novel Monoclonal Antibody to CD40 Prolongs Islet Allograft Survival
- (2012) M. Lowe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
- (2012) Baochun Zhang et al. CELL
- Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature
- (2012) G. L. Kelly et al. JOURNAL OF VIROLOGY
- The Latent Membrane Protein 1 (LMP1) Oncogene of Epstein-Barr Virus Can Simultaneously Induce and Inhibit Apoptosis in B Cells
- (2012) Zachary L. Pratt et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
- (2012) S.-D. Ma et al. JOURNAL OF VIROLOGY
- B-cell activating factor targeted therapy and lupus
- (2012) Alexis Boneparth et al. ARTHRITIS RESEARCH & THERAPY
- A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
- (2011) L. Giulino et al. BLOOD
- Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection
- (2011) A. Haas et al. JOURNAL OF VIROLOGY
- Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression
- (2011) L. Wang et al. JOURNAL OF VIROLOGY
- Lymphomas differ in their dependence on Epstein-Barr virus
- (2010) D. T. Vereide et al. BLOOD
- T-cell/histiocyte-rich large B-cell lymphoma
- (2010) S. Pittaluga et al. HAEMATOLOGICA
- Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rγnull mice
- (2010) Deepika Rajesh et al. HUMAN IMMUNOLOGY
- Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
- (2010) John P. Graham et al. IMMUNOLOGICAL REVIEWS
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
- (2010) S.-D. Ma et al. JOURNAL OF VIROLOGY
- CD40 Ligand (CD154) Incorporated into HIV Virions Induces Activation-Induced Cytidine Deaminase (AID) Expression in Human B Lymphocytes
- (2010) Marta Epeldegui et al. PLoS One
- IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma
- (2009) Donatella Aldinucci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
- (2009) Till Strowig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
- (2009) J. M. Brooks et al. JOURNAL OF IMMUNOLOGY
- CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus Infection
- (2008) Mario Cocco et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis
- (2008) C. Le Clorennec et al. JOURNAL OF VIROLOGY
- IRF4 addiction in multiple myeloma
- (2008) Arthur L. Shaffer et al. NATURE
- Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice
- (2008) Madelyn R. Schmidt et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now